Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 21.88
+0.42 (1.96%)
At close: Feb 12, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 134.42 million as of February 13, 2026. Its market cap has increased by 229.88% in one year.
Market Cap
134.42M
Enterprise Value
142.53M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.88
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 134.42M, a decrease of -69.70%. That is a compound annual growth rate of -9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 134.42M | 395.56% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 161.38M |
| Sunrest Lifescience | 157.92M |
| Hamps Bio | 149.85M |
| Colinz Laboratories | 144.39M |
| Norris Medicines | 140.01M |
| Emmessar Biotech & Nutrition | 135.84M |
| Cian Healthcare | 125.23M |
| Shamrock Industrial Company | 110.51M |